BridgeBio Pharma (BBIO) Total Debt (QoQ) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | BridgeBio Pharma | 12.91 Bn | 11.98 Bn | 184.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 128.30% |
| Dec 31, 2025 | -23.75% |
| Dec 31, 2024 | 24.98% |
| Sep 30, 2024 | 0.18% |
| Jun 30, 2024 | 0.17% |
| Mar 31, 2024 | -2.63% |
| Dec 31, 2023 | 1.07% |
| Sep 30, 2023 | 0.28% |
| Jun 30, 2023 | 1.09% |
| Mar 31, 2023 | 1.11% |
| Dec 31, 2022 | 1.90% |
| Sep 30, 2022 | 1.10% |
| Jun 30, 2022 | -3.63% |
| Mar 31, 2022 | 0.78% |
| Dec 31, 2021 | 317.65% |
| Sep 30, 2021 | 0.51% |
| Jun 30, 2021 | 8.69% |
| Mar 31, 2021 | 0.56% |
| Dec 31, 2020 | 0.52% |
| Sep 30, 2020 | 0.52% |
| Jun 30, 2020 | 0.53% |
| Mar 31, 2020 | 0.68% |
| Dec 31, 2019 | 22.36% |
| Sep 30, 2019 | 0.03% |